<!DOCTYPE html>
<html manifest="manifest.manifest">
<head>
	<meta http-equiv=Content-Type content="text/html; charset=utf-8">
	<title>MRCG Clinical Guidelines</title>
	<meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=2.0, user-scalable=1">
  
	<meta name=Generator content="Microsoft Word 14 (filtered)">
		<link rel="stylesheet" href="jquery.mobile-1.4.5.min.css" />
	<link rel="stylesheet" href="mystyle.css" />
	<script src="jquery-1.11.1.min.js"></script>
	<script src="jquery.mobile-1.4.5.min.js"></script>
	<script type="text/javascript" src="cordova.js"></script>
	<script>
	    		$(function(){
			$("[data-role='header'], [data-role='footer']").toolbar();
		});
  	  $(document).one('pagebeforecreate', function () {
	        $('input[data-type="search"]').val("");
	    	        $.get("panel.html", function (data2) {
            $.mobile.pageContainer.prepend(data2);
              $("[data-role=panel]").panel().enhanceWithin();
        }, "html");
	           $.get("header.html", function (data) {
      $.mobile.pageContainer.prepend(data);
      $("[data-role='header']").toolbar().enhanceWithin();
    }, "html");
    $.get("footer.html", function (data) {
      $.mobile.pageContainer.append(data);
      $("[data-role='footer']").toolbar().enhanceWithin();
    }, "html");
        $('.WordSection1').wrap('<div role="main" class="ui-content">');
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $.mobile.pageContainer.enhanceWithin();
	  });
	        $(document).bind( "pagechange", function( ) {
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $('.tableCont').enhanceWithin();
      } );
			// When the user scrolls down 20px from the top of the document, show the button
		window.onscroll = function() {scrollFunction()};
		function scrollFunction() {
		  if (document.body.scrollTop > 20 || document.documentElement.scrollTop > 20) {
			document.getElementById("myBtn").style.display = "block";
		  } else {
			document.getElementById("myBtn").style.display = "none";
		  }
		}
		// When the user clicks on the button, scroll to the top of the document
		function topFunction() {
		  document.body.scrollTop = 0; // For Safari
		  document.documentElement.scrollTop = 0; // For Chrome, Firefox, IE and Opera
		}</script>      
	





	






  
  
  	
</head>
<body lang=EN-GB link=blue vlink=purple>
	
<div data-role="page">
	<div role="main" class="ui-content">
<div class=WordSection1>
<h1><span lang=EN-US>Congenital heart disease</span></h1>
<h2><i><span lang=EN-US>Executive summary</span></i></h2>
<h2><span lang=EN-US>Introduction</span></h2>
<p class=MsoNormal><span lang=EN-US>Congenital heart defects (CHD) are problems
with the structure of the heart that are present at birth. It is caused by
abnormal formation of the heart during foetal development. In most cases when a
baby is born with a congenital heart defect, there is no known cause for it.
CHD are classified into two broad categories, acyanotic (ACHD) and cyanotic
lesions (CCHD). The most common acyanotic lesions are ventricular septal defect
(VSD), atrial septal defect (ASD), atrioventricular canal defects and patent ductus
arteriosus (PDA). In patients with Cyanotic congenital heart defects, the blood
that is pumped around the body contains less than normal levels of oxygen
causing the child to have bluish tinge to the skin and mucous membranes.
Tetralogy of Fallot is the most common cyanotic heart defect but may not always
become apparent immediately after birth. </span></p>
<p class=MsoNormal><span lang=EN-US>CHDs are the most common cause of infant
death due to birth defects. Approximately 25% of children born with a CHD will
need heart surgery or other interventions to survive.  MRCG has an ongoing
collaboration with the Chain of Hope charity which assist in management of
children with CHD, by making arrangements for surgical treatment overseas for
those children who will benefit. Please review the current SOP or discuss with
a consultant if you need more advice about how to ensure children with CHD are
included in this programme.</span></p>
<h2><span lang=EN-US>Target users</span></h2>
<p class=MsoListParagraphCxSpFirst style='margin-bottom:8.0pt;text-indent:-18.0pt;
line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Doctors</span></p>
<p class=MsoListParagraphCxSpLast style='margin-bottom:8.0pt;text-indent:-18.0pt;
line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Nurses</span></p>
<h2><span lang=EN-US>Target area of use </span></h2>
<p class=MsoListParagraphCxSpFirst style='margin-bottom:8.0pt;text-indent:-18.0pt;
line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Outpatient department</span></p>
<p class=MsoListParagraphCxSpLast style='margin-bottom:8.0pt;text-indent:-18.0pt;
line-height:107%'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Ward</span></p>
<h2><span lang=EN-US>Key areas of focus / New additions / Changes </span></h2>
<p class=MsoNormal><span lang=EN-US>This guideline outlines the diagnosis and
management of congenital heart defects.</span></p>
<h2><span lang=EN-US>Limitations</span></h2>
<p class=MsoNormal><span lang=EN-US>Patients with congenital heart disease need
to be referred overseas for surgical repair. This is best achieved through
ongoing care at our clinic and attendance at our periodic screening clinic
(about once per year) run by Chain of Hope, who can arrange sponsorship for
eligible children.</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
lang=EN-US style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2><span lang=EN-US>Presenting symptoms and signs</span></h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Failure to thrive (Small for age)</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Feeding difficulties</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Diaphoresis</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Respiratory distress</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Cyanosis (in cyanotic CHD)</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Cardiac murmurs</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Detection of a heart murmur - need to
differentiate innocent from pathological</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Shock - when duct closes in severe left heart
obstruction</span></p>
<h2><span lang=EN-US>Examination findings</span></h2>
<p class=MsoNormal><span lang=EN-US>Full cardiac and respiratory examination is
important, including basic observations, inspection, palpation and
auscultation. </span></p>
<p class=MsoNormal><span lang=EN-US>Pulse oximetry is helpful to identify oxygen
saturations. </span></p>
<h2><span lang=EN-US>Investigations</span></h2>
<p class=MsoNormal><span lang=EN-US>ECHO is the gold standard for making the
diagnosis. </span></p>
<p class=MsoNormal><span lang=EN-US>Other tests that might be helpful include:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>CXR – to see if the heart is enlarged or if
there are signs of left heart failure.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>ECG – to identify rhythm problems. </span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Cardiac catheterization is not available in
Gambia – but can help determine the function of the heart valves and chambers. </span></p>
<h2><span lang=EN-US>Management</span></h2>
<p class=MsoNormal><span lang=EN-US>The management of CHD depends on the exact
problem identified – these are described below. </span></p>
<h3><span lang=EN-US>Asymptomatic Child With a Systolic Murmur </span></h3>
<p class=MsoNormal><span lang=EN-US>When murmur is identified in an asymptomatic
child 2 years of age or older, the child should be evaluated with full history,
examination, CXR (and perhaps ECG). </span></p>
<p class=MsoNormal><span lang=EN-US>ECHO is reserved for selected cases where
the history and physical findings are atypical for an innocent murmur. Once a
murmur is determined to be innocent, further cardiac evaluation is unnecessary.</span></p>
<h3><span lang=EN-US>Ventricular Septal Defect</span></h3>
<h4><span lang=EN-US style='font-family:"Arial","sans-serif";color:black'>Small
VSD</span></h4>
<p class=MsoNormal><span lang=EN-US>In most patients, a small VSD is a
relatively benign condition. It is important to monitor these patients to
detect and manage the relatively rare but important complications of
endocarditis, arrhythmias, aortic regurgitation and subvalvular pulmonary
stenosis and discrete subaortic stenosis.</span></p>
<p class=MsoNormal><span lang=EN-US>Clinical examination and ECHO are adequate
to establish the diagnosis. </span></p>
<p class=MsoNormal><span lang=EN-US>Children with a small VSD are often asymptomatic
and have an excellent long-term prognosis. Neither medical therapy nor surgical
therapy is indicated. Prophylactic antibiotic therapy against endocarditis is
no longer indicated in most cases.</span></p>
<h4><span lang=EN-US style='font-family:"Arial","sans-serif";color:black'>Moderate
to large VSD</span></h4>
<p class=MsoNormal><span lang=EN-US>In moderate or large VSDs, medical therapy
is indicated to manage symptomatic congestive heart failure (CHF). This may
include:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span lang=EN
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN>Increase feeds to ensure adequate weight gain.
Occasionally, oral feeds must be supplemented with nasogastric tube feedings,
because a baby in CHF may be unable to consume adequate calories for
appropriate weight gain.</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-bottom:8.0pt;text-indent:
-18.0pt;line-height:107%'><span lang=EN style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN>Furosemide to relieve pulmonary congestion – give
1-3 mg/kg/day divided into 2 or 3 doses. Long-term furosemide treatment may
result in hypercalciuria, renal damage, and electrolyte disturbances.</span></p>
<p class=MsoListParagraphCxSpLast style='margin-bottom:8.0pt;text-indent:-18.0pt;
line-height:107%'><span lang=EN style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN>ACE inhibitors (eg captopril and ramipril) reduce
both the systemic and pulmonary pressures (the former to a greater degree),
thereby reducing the left-to-right shunt.</span></p>
<p class=MsoNormal><span lang=EN-US>Uncontrolled CHF with growth failure and
recurrent respiratory infection is an indication for immediate surgical repair.
Neither the age nor the size of the patient is prohibitive in considering
surgery.Ideally, surgery is performed at 3 – 6 months of age to prevent
permanent lung damage from pulmonary hypertension.</span></p>
<h3><span lang=EN-US>Patent Ductus Arteriosus (PDA)</span></h3>
<p class=MsoNormal><span lang=EN-US>In most cases, Doppler ECHO is adequate to
confirm the diagnosis. Cardiac catheterization is necessary only in atypical
cases. </span></p>
<p class=MsoNormal><span lang=EN-US>Treatment is by elective closure of the PDA.</span></p>
<p class=MsoNormal><span lang=EN-US>When the duct is large complications
include infective arteritis, aneurysm of the ductus, congestive heart failure,
pulmonary vascular obstructive disease, and calcification of the ductus.</span></p>
<h3><span lang=EN-US>Atrial Septal Defect (ASD)</span></h3>
<p class=MsoNormal><span lang=EN-US>There are two main types of ASD – secundum
ASD (80% of ASD) and partial atrioventricular septal defect AVSD or primum ASD.
Both present with similar symptoms and signs but their anatomy is different.</span></p>
<p class=MsoNormal><span lang=EN-US>Patient may have no symptoms or may present
with recurrent chest infections and wheeze. ECHO is the mainstay of diagnosis.</span></p>
<p class=MsoNormal><span lang=EN-US>Once an ASD is found at ECHO, an assessment
of shunt size is made. </span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Small shunt: Absence of diastolic flow rumble,
normal chest X-ray, ECHO evidence of normal right ventricular size and normal
interventricular septal motion or a pulmonary to systemic flow ratio (QP/QS)
&lt;1.5.</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Large shunt: Presence of a diastolic flow rumble
or ECG evidence of right ventricular hypertrophy, CXR evidence of cardiomegaly
or increased pulmonary vascular markings, or ECHO evidence of right ventricular
enlargement or paradoxical septal motion or a QP/QS 1.5.</span></p>
<p class=MsoNormal><span lang=EN-US>Many small ASDs close spontaneously below
the age of 2 years and some up to the age of 4 years, therefore conservative
treatment is indicated if the patient is under age 4 years and asymptomatic.
Even those with symptoms and a large left-to-right shunt can be observed up to
the age of 5 years. </span></p>
<p class=MsoNormal><span lang=EN-US>If the ASD does not close spontaneously,
then surgical closure is indicated at 3-5 years of age in order to prevent
right heart failure and arrhythmias in later life.</span></p>
<h3><span lang=EN-US>Tetralogy of Fallot (TOF)</span></h3>
<p class=MsoNormal><span lang=EN-US>TOF is the most frequent cyanotic
congenital heart disease. The four cardinal anatomic features are a large VSD,
overriding of the aorta, subpulmonary stenosis causing right ventricular
outflow tract obstruction (RVOTO) and right ventricular hypertrophy. The
severity of RVOTO determines the extent of R-L shunting on ventricular level
and therefore the extent of cyanosis.</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-US>Severe RVOTO</span></b><span lang=EN-US>
results in deep cyanosis due to a large R-L shunt.</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><b><span lang=EN-US>Mild RVOTO</span></b><span lang=EN-US> does
not cause cyanosis (“pink Fallot”) and may result in heart failure due to large
L-R shunting on ventricular level</span></p>
<p class=MsoNormal><i><span lang=EN-US>Examination findings</span></i></p>
<p class=MsoNormal><span lang=EN-US>Central cyanosis and a systolic murmur, caused
by PS with the intensity inversely correlated with severity of PS. The VSD is
not associated with a murmur</span><span lang=EN-US>!  </span></p>
<p class=MsoNormal><i><span lang=EN-US>Investigations</span></i></p>
<p class=MsoNormal><span lang=EN-US>Echocardiography is the cornerstone for the
diagnosis. Chest X-ray and ECG may be helpful.</span></p>
<p class=MsoNormal><span lang=EN-US>Pulse oximetry at each clinical visit. If O<sub>2</sub>
saturations repeatedly &lt; 80%, treatment is mandatory. </span></p>
<p class=MsoNormal><i><span lang=EN-US>Management of cyanotic spells</span></i></p>
<p class=MsoNormal><span lang=EN-US>These are caused by </span><span
lang=EN-US>acute obstruction of RVOT or acute decrease of peripheral
resistance. </span></p>
<p class=MsoNormal><span lang=EN-US>They present with:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Increase of cyanosis</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Tachycardia</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Auscultation decreased intensity of systolic
heart murmur due to reduced flow into PA</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Seizures (neurological sequelae) </span></p>
<p class=MsoNormal><span lang=EN-US>Older untreated children have signs of
chronic hypoxaemia including digital clubbing. They are at risk of endocarditis
and brain abscess and these risks increase with age, raised Hb and iron
deficiency. </span></p>
<p class=MsoNormal><i><span lang=EN-US>Emergency treatment</span></i></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Increase peripheral resistance by encouraging
knee-to-chin position</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Administer oxygen</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Sedation: Morphine sc or iv 0.1-0.2 mg/kg OR Midazolam
iv 0.1 mg/kg OR Midazolam Rectal 0.5 mg/kg OR Ketamine iv 1-2 mg/kg OR Ketamine
im 5 mg/kg.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Give fluid: iv bolus of 10 ml/kg of normal
saline which can be repeated. </span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Give betablocker: iv propranolol 15-20 mcg/kg –
repeat up to a maximum of 100 mcg/kg. Once child is improving, continue with
doses of 15-20 mcg/kg up to 6 hourly until able to take it orally. </span></p>
<i><span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span></i>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><i><span
lang=EN-US>&nbsp;</span></i></p>
<p class=MsoNormal><i><span lang=EN-US>Ongoing treatment</span></i></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Oral propranolol 2-6 mg/kg/day in divided doses.</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Iron replacement as despite the plethora, children
with TOF are often iron deficient. </span></p>
<p class=MsoNormal><span lang=EN-US>Surgical repair involves enlargement of
RVOT and VSD closure.</span></p>
<h3><span lang=EN-US>Children who have had surgery for CHD</span></h3>
<p class=MsoNormal><span lang=EN-US>Review patients in clinic about 3 months after
surgery. Check for resolution of all post-operative problems. Examine the
patient fully. </span></p>
<p class=MsoNormal><span lang=EN-US>Look for important complications such as
arrhythmia and pulmonary valve insufficiency.</span></p>
<p class=MsoNormal><span lang=EN-US>ECHO to confirm successful treatment is
usually done by the surgeons, but may need to be repeated here.</span></p>
<p class=MsoNormal><span lang=EN-US>ECG, CXR and other tests to assess the
patient may be needed if there are any abnormal clinical findings. </span></p>
<h3><span lang=EN-US>Antibiotic prophylaxis for dental procedures</span></h3>
<p class=MsoNormal><span lang=EN-US>Many patients with congenital cardiac
defects require prophylaxis for bacterial endocarditis when undergoing certain
surgical and dental procedures. Antibiotics before dental procedures are only
recommended for patients with the highest risk of infective endocarditis:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>A prosthetic heart valve or who have had a heart
valve repaired with prosthetic material.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>A history of endocarditis.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>A heart transplant with abnormal heart valve
function</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Certain congenital heart defects including: </span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>CCHD that has not been fully repaired, including
children who have had a surgical shunts and conduits.</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>CHD that's been completely repaired with
prosthetic material or a device for the first six months after the repair
procedure.</span></p>
<p class=MsoListParagraphCxSpLast style='margin-left:72.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Repaired CHD  with residual defects, such as
persisting leaks or abnormal flow at or adjacent to a prosthetic patch or
prosthetic device.</span></p>
<h2><span lang=EN-US>References</span></h2>
<h2><span lang=EN style='font-size:10.0pt;color:black;font-weight:normal'>Lissauer,
T., Carroll, W., &amp; Craft, A. (2018). <i>Illustrated textbook of paediatrics</i>.
Fifth Edition. Elsevier</span></h2>
<div class="tableCont">
  <table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Written by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Name: Baderinwa Abatan</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Date: 31 July 2018</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Reviewed by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Name: Karen Forrest</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Date: 31 July 2018</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Version:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Change history:</span></b></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Review due date:</span></b></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>1.0</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>New document</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>31 July 2020</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>1.1</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Executive summary added</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>31 July 2020</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Review Comments (<i>if applicable)</i></span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>&nbsp;</span></b></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
</div>
</div><!-- /content -->

</div>

</body>
</html>
